HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
HRTX on Nasdaq
Shares outstanding
182,615,507
Price per share
$1.34
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
156,212,113
Total reported value
$203,061,227
% of total 13F portfolios
0%
Share change
+3,946,709
Value change
+$5,426,353
Number of holders
167
Price from insider filings
$1.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rubric Capital Management LP 16% -8.9% $37,859,003 +$1,192,086 30,046,828 +3.3% Rubric Capital Management LP 15 Oct 2025
Clearline Capital LP 6.7% +28% $18,108,154 +$3,733,614 12,235,239 +26% Clearline Capital LP 31 Dec 2025
VANGUARD GROUP INC 5.4% +15% $12,766,499 +$1,768,780 9,820,384 +16% The Vanguard Group 31 Dec 2025

As of 31 Dec 2025, 167 institutional investors reported holding 156,212,113 shares of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX). This represents 86% of the company’s total 182,615,507 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Rubric Capital Management LP 16% 30,046,828 +3.3% 0.47% $39,060,876
Clearline Capital LP 6.7% 12,235,239 +26% 1.2% $15,905,811
ADAGE CAPITAL PARTNERS GP, L.L.C. 6.1% 11,185,325 +9.2% 0.02% $14,540,923
BlackRock, Inc. 5.6% 10,218,236 +2.3% 0% $13,283,708
VANGUARD GROUP INC 5.4% 9,820,384 +16% 0% $12,766,499
Velan Capital Investment Management LP 4.8% 8,753,290 0% 6.6% $11,379,277
MILLENNIUM MANAGEMENT LLC 3.9% 7,169,908 +2785% 0.01% $9,320,880
PALISADE CAPITAL MANAGEMENT, LP 3.5% 6,326,113 -14% 0.24% $8,223,947
TANG CAPITAL MANAGEMENT LLC 3.4% 6,250,000 +81% 0.4% $8,125,000
Tejara Capital Ltd 2.8% 5,131,426 +12% 2.8% $6,670,854
GEODE CAPITAL MANAGEMENT, LLC 2.2% 4,081,222 +12% 0% $5,306,435
STATE STREET CORP 2.1% 3,778,043 +3.5% 0% $4,911,456
JW Asset Management, LLC 2% 3,671,073 +11% 1.6% $4,772,395
Congress Park Capital LLC 1.7% 3,067,475 +6.1% 1.2% $3,987,718
D. E. Shaw & Co., Inc. 1.6% 3,004,640 -2.7% 0% $3,906,032
NEW YORK STATE COMMON RETIREMENT FUND 1.4% 2,576,716 0% 0% $3,349,731
CITADEL ADVISORS LLC 1.1% 2,095,045 -23% 0% $2,723,559
UBS Group AG 1.1% 2,091,669 -29% 0% $2,719,170
RENAISSANCE TECHNOLOGIES LLC 1% 1,915,900 -33% 0% $2,490,670
Pale Fire Capital SE 0.8% 1,469,655 +212% 0.25% $1,910,552
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.78% 1,415,336 +11% 0% $1,839,937
JANE STREET GROUP, LLC 0.75% 1,367,891 +521% 0% $1,778,259
Stonepine Capital Management, LLC 0.68% 1,237,802 +46% 1.3% $1,609,143
Monaco Asset Management SAM 0.68% 1,233,022 +23% 0.48% $1,602,929
NORTHERN TRUST CORP 0.6% 1,091,411 -5.7% 0% $1,418,835

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 156,212,113 $203,061,227 +$5,426,353 $1.30 167
2025 Q3 152,658,767 $192,362,843 +$22,498,799 $1.26 171
2025 Q2 131,463,843 $272,131,676 +$12,999,478 $2.07 170
2025 Q1 124,770,231 $274,489,898 +$21,979,195 $2.20 164
2024 Q4 114,941,581 $175,829,179 -$13,146,397 $1.53 161
2024 Q3 121,816,811 $242,421,216 -$29,164,536 $1.99 169
2024 Q2 129,609,461 $453,638,008 +$35,415,047 $3.50 189
2024 Q1 119,262,673 $330,361,469 +$19,698,437 $2.77 157
2023 Q4 112,451,511 $191,165,565 +$1,074,277 $1.70 149
2023 Q3 118,378,841 $121,934,068 +$19,982,956 $1.03 138
2023 Q2 98,652,577 $114,435,495 -$11,706,623 $1.16 143
2023 Q1 107,852,430 $162,855,915 -$15,688,602 $1.51 153
2022 Q4 115,831,665 $289,582,111 -$29,877,564 $2.50 175
2022 Q3 121,963,764 $514,346,608 +$45,998,596 $4.22 178
2022 Q2 115,204,514 $321,404,107 +$4,826,591 $2.79 160
2022 Q1 108,535,070 $620,478,626 -$95,435,236 $5.72 176
2021 Q4 117,646,567 $1,073,655,355 +$78,398,633 $9.13 192
2021 Q3 108,488,554 $1,160,926,758 +$41,634,303 $10.69 189
2021 Q2 103,864,409 $1,612,145,175 +$202,378,763 $15.52 182
2021 Q1 89,846,972 $1,456,395,898 -$11,223,795 $16.21 186
2020 Q4 90,262,699 $1,910,380,366 +$26,526,144 $21.16 180
2020 Q3 90,857,946 $1,346,585,988 +$33,105,054 $14.82 177
2020 Q2 88,614,685 $1,334,393,703 -$51,210,796 $14.71 185
2020 Q1 92,095,623 $1,081,183,715 -$131,875,186 $11.74 186
2019 Q4 99,047,059 $2,326,444,060 +$183,809,453 $23.50 194
2019 Q3 91,435,188 $1,691,767,958 -$43,730,310 $18.50 175
2019 Q2 93,875,302 $1,744,712,239 +$2,233,456 $18.59 170
2019 Q1 92,662,760 $2,264,521,795 +$28,820,026 $24.44 189
2018 Q4 91,350,119 $2,369,031,974 +$92,438,916 $25.94 169
2018 Q3 87,463,202 $2,768,171,136 +$131,977,881 $31.65 187
2018 Q2 77,152,541 $2,997,578,965 +$216,890,926 $38.85 192
2018 Q1 72,567,037 $2,001,875,074 +$342,791,800 $27.60 149
2017 Q4 60,500,377 $1,095,067,241 +$103,341,807 $18.10 120
2017 Q3 63,406,329 $1,024,008,242 -$88,424,754 $16.15 101
2017 Q2 69,617,065 $964,195,934 +$47,548,351 $13.85 102
2017 Q1 71,661,852 $1,074,958,781 +$337,458,954 $15.00 98
2016 Q4 52,666,446 $689,938,271 +$4,719,852 $13.10 94
2016 Q3 51,265,727 $883,246,939 +$71,930,213 $17.23 88
2016 Q2 46,993,886 $848,220,501 +$35,391,534 $18.05 90
2016 Q1 45,017,464 $854,951,019 -$8,625,778 $18.99 98
2015 Q4 45,438,610 $1,214,308,493 +$39,761,438 $26.70 103
2015 Q3 43,669,932 $1,064,954,183 +$173,790,187 $24.40 101
2015 Q2 36,118,773 $1,125,171,985 +$319,523,410 $31.16 86
2015 Q1 26,445,484 $384,782,059 +$31,452,121 $14.55 68
2014 Q4 24,573,735 $247,206,453 +$2,536,942 $10.06 62
2014 Q3 24,229,222 $201,828,829 -$7,802,513 $8.33 56
2014 Q2 26,551,442 $327,060,299 +$69,901,807 $12.32 67
2014 Q1 20,801,929 $289,178,683 +$283,529,683 $13.91 39